Gershenwald JE - Search Results

1

Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA. Long GV, et al. Among authors: gershenwald je. Lancet. 2023 Aug 5;402(10400):485-502. doi: 10.1016/S0140-6736(23)00821-8. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499671 Review.

2

Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck.

Bonnen MD, Ballo MT, Myers JN, Garden AS, Diaz EM Jr, Gershenwald JE, Morrison WH, Lee JE, Oswald MJ, Ross MI, Ang KK. Bonnen MD, et al. Among authors: gershenwald je. Cancer. 2004 Jan 15;100(2):383-9. doi: 10.1002/cncr.11921. Cancer. 2004. PMID: 14716775 Free article.

3

The new staging system for cutaneous melanoma in the era of lymphatic mapping.

Rousseau DL Jr, Gershenwald JE. Rousseau DL Jr, et al. Among authors: gershenwald je. Semin Oncol. 2004 Jun;31(3):415-25. doi: 10.1053/j.seminoncol.2004.03.018. Semin Oncol. 2004. PMID: 15190500 Review.

4

Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients.

Scolyer RA, Thompson JF, McCarthy SW, Gershenwald JE, Ross MI, Cochran AJ. Scolyer RA, et al. Among authors: gershenwald je. J Am Coll Surg. 2005 Nov;201(5):821-3; author reply 823-4. doi: 10.1016/j.jamcollsurg.2005.07.017. J Am Coll Surg. 2005. PMID: 16256927 No abstract available.

5

Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.

Pawlik TM, Ross MI, Prieto VG, Ballo MT, Johnson MM, Mansfield PF, Lee JE, Cormier JN, Gershenwald JE. Pawlik TM, et al. Among authors: gershenwald je. Cancer. 2006 Feb 15;106(4):900-6. doi: 10.1002/cncr.21635. Cancer. 2006. PMID: 16411225 Free article.

6

Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell.

Scolyer RA, Murali R, Gershenwald JE, Cochran AJ, Thompson JF. Scolyer RA, et al. Among authors: gershenwald je. Ann Oncol. 2007 Apr;18(4):806-8. doi: 10.1093/annonc/mdm081. Ann Oncol. 2007. PMID: 17389530 Free article. No abstract available.

7

Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease.

Anaya DA, Xing Y, Feng L, Huang X, Camacho LH, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Cormier JN. Anaya DA, et al. Among authors: gershenwald je. Cancer. 2008 May 1;112(9):2030-7. doi: 10.1002/cncr.23399. Cancer. 2008. PMID: 18320602 Free PMC article.

8

Clinical value of the sentinel-node biopsy in primary cutaneous melanoma.

Balch CM, Gershenwald JE. Balch CM, et al. Among authors: gershenwald je. N Engl J Med. 2014 Feb 13;370(7):663-4. doi: 10.1056/NEJMe1313690. N Engl J Med. 2014. PMID: 24521113 No abstract available.

9

A highly recurrent RPS27 5'UTR mutation in melanoma.

Dutton-Regester K, Gartner JJ, Emmanuel R, Qutob N, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Scolyer RA, Mann GJ, Thompson JF, Hayward NK, Samuels Y. Dutton-Regester K, et al. Among authors: gershenwald je. Oncotarget. 2014 May 30;5(10):2912-7. doi: 10.18632/oncotarget.2048. Oncotarget. 2014. PMID: 24913145 Free PMC article.

10

Genomic Classification of Cutaneous Melanoma.

Cancer Genome Atlas Network. Cancer Genome Atlas Network. Cell. 2015 Jun 18;161(7):1681-96. doi: 10.1016/j.cell.2015.05.044. Cell. 2015. PMID: 26091043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page